StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note issued to investors on Monday. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Up 0.2 %
Shares of NASDAQ RKDA opened at $4.86 on Monday. The firm has a 50-day simple moving average of $5.28 and a 200-day simple moving average of $3.86. The stock has a market capitalization of $6.61 million, a price-to-earnings ratio of -1.14 and a beta of 0.88. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31.
Arcadia Biosciences Company Profile
Further Reading
- Five stocks we like better than Arcadia Biosciences
- How Can Investors Benefit From After-Hours Trading
- 3 Must-Have ETFs Set to Dominate This Quarter
- What is a Special Dividend?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Invest in the Best Canadian StocksĀ
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.